Routine HbA1c among hematology and oncology inpatients: Diabetes-status and hospital-outcomes
Wei-Ling Chiu, Leonid Churilov, Chee-Hau Lim, Alanna Tan, Rithin Nedumannil, Lik-Hui Lau, Jeremy Lew, Mariam Hachem, Alvin Kong, Raymond Robbins, Harvey Sutcliffe, Que Lam, Andrew Lee, Frida Djukiadmodjo, Natalie Nanayakkara, Jeffrey D Zajac, Elif I Ekinci
Diabetes Research and Clinical Practice | ELSEVIER IRELAND LTD | Published : 2019
AIMS: Using routine HbA1c measurement to determine the prevalence of diabetes mellitus (known and previously unrecognized) and their hospital outcomes among hematology and oncology inpatients. METHODS: This was a prospective, observational study. Routine automated HbA1c testing was performed in all hematology and oncology inpatients aged ≥54 years at a tertiary hospital, July 2013-January 2015. The outcome measures were: (i) prevalence of known and previously unrecognized diabetes, and (ii) hospital outcomes: length-of-stay (LOS), intensive-care-unit (ICU) admission, 30-day/18-month readmission, and 18-month mortality. RESULTS: Over the 18-month study period, 1076 inpatients aged ≥54 years w..View full abstract
A/Prof Ekinci was supported by an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship, Viertel Clinical Investigatorship, Royal Australasian College of Physicians (RACP) Fellowship and Sir Edward Weary Dunlop Medical Research Foundation Research Grant.